About us

Overview

Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

The company holds a unique place on the market with all of its laboratories on one site, 250 highly-qualified professionals and more than 40 years’ expertise at the forefront of analytical sciences.

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences. For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Mitose

History of Quality Assistance

2023
© Valentin Bianchi - Hans Lucas
Nathalie Draux succeeds Philippe Draux as CEO of Quality Assistance

New milestone:
More than 250 employees

We are proud to have as many individuals on our Team who are committed to the essential role we play in public health and as an analytical CRO partner with pharmaceutical companies.

Quality Assistance milestone 250 employees

MITOSE 2022 Quality Assistance
2022
Quality Assistance replicates its DNA and expands from 6,000 to 12,000 m²
https://mitose.quality-assistance.com/
Quality Assistance 2021
2021
Challenge 2015-2021: Quality Assistance achieves its 2015 goal of 500 innovative drugs.
6000 m²
Quality Assistance 2020 200 team members
2020
200 team members

Reaching 200 highly qualified team members in August 2020

fda logo
2019
Food and Drug Administration (USA)

The FDA has successfully inspected Quality Assistance.

BNP Paribas Fortis logo
2017
BNP Paribas Fortis Private Equity Management S.A. enters the capital and the Board of Directors of Quality Assistance S.A.
quality assistance logo
2015
New expansion for Quality Assistance

Acquisition of 5 hectares of land opposite its current facilities for future operational capacity increase
 

logo-anvisa
2012
Agência Nacional de Vigilância Sanitária (Brazil)

ANVISA successfully inspected Quality Assistance in 2012 to verify compliance with Good Practices in Bioavailability/Bioequivalence of Medicines, in accordance with Law N°9,782/99 and Resolution R.D.C./ANVISA N° 103, of 08 May 2003. Quality Assistance is registered with ANVISA as a contract Bioequivalence facility.

logo_gclp-logo_pmda-logo-gcp
2009
PDMA, GCLP, GCP

Pharmaceuticals and Medical Devices Agency (Japan)
In March 2009, Quality Assistance was successfully inspected by the PDMA and received GMP compliance certification from the Japanese authorities.

Good Clinical Laboratory Practice Compliance
Quality Assistance has adapted its quality system to meet the requirements of sponsors who need the analysis of their samples from clinical trials to be done in accordance with GCLP (Good Clinical Laboratory Practice).

Good Clinical Practice Compliance
Quality Assistance has adapted its quality system to meet the requirements of sponsors who need the analysis of their samples from clinical trials to be done in accordance with GCP (Good Clinical Practice).

Quality assistance logo
2008
Valois S.C.R.L. enters the capital and the Board of Directors of Quality Assistance S.A.
5200 m²
97 employees
logo-glp
2004
Good Laboratory Practice Compliance

Quality Assistance is authorized by the Belgian authorities (Scientific Institute of Public Health) to carry out toxicity studies, residue studies, analytical and clinical chemistry testing, and pharmacokinetic studies according to the requirements of Good Laboratory Practice (GLP) - Directive of the European Commission 2004/9/EEC.

logo-fda
2003
Food and Drug Administration (USA)

The FDA has successfully inspected Quality Assistance. Accordingly, Quality Assistance has been accepted and registered with the FDA as a contract pharmaceutical testing facility (FDA-FEI number 3002367943).

Continuous growth
2002
Continuous growth
3200 m²
60 employees
logo-sriw
2001
Société Régionale d'Investissement de Wallonie (SRIW S.A.) enters the capital and the Board of Directors of Quality Assistance S.A.

Sambrinvest becomes a Board Observer

logo-sambrinvest
1998
Sambrinvest becomes a Member of the Board of Directors
quality assistance logo
1997
Quality Assistance S.P.R.L. becomes a limited company: Quality Assistance S.A.
1992-quality-assistance-donstiennes
1993
PHARMANAL S.P.R.L. is renamed Quality Assistance S.P.R.L.
Quality Assistance History 1992
1992
Move to Donstiennes, Belgium
1200 m²
15 employees
1985-quality-assistance-charleroi-history
1985
Move to Charleroi, Belgium
200 m²
3 employees
GMP
1984
Good Manufacturing Practice Compliance

In accordance with the Royal Decree of 22/09/1966*, Quality Assistance is certified by the Belgian Federal Agency for Medicines and Health Products to perform the analysis of medicinal products. 

1982
Company establishment

as PHARMANAL S.P.R.L.